
Nanobiotix Investor Relations Material
Latest events

Status Update
Nanobiotix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Nanobiotix S.A.
Access all reports
Nanobiotix S.A. is a biotechnology company that focuses on developing nanomedicine products for cancer treatment. The company's proprietary technology, NanoXray, involves nanoparticles that enhance the effects of radiotherapy by increasing the absorption of X-rays within cancer cells. This approach is designed to improve the precision and effectiveness of radiotherapy, potentially reducing side effects and improving patient outcomes. Nanobiotix's products are primarily in the clinical stages of development, and the company continues to advance its pipeline for various cancer types. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Key slides for Nanobiotix S.A.


Study Update
Nanobiotix S.A.


H2 2023
Nanobiotix S.A.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
NANO
Country
🇫🇷 France